The company added that its US FDA-approved product is therapeutically equivalent to Sandoz Inc.’s reference listed drug Arranon Injection.

Alembic Pharma Gets US FDA Nod For Generic Cancer Drug

Alembic Pharmaceuticals said that it has received final approval from the US Food & Drug Administration (US FDA) for its abbreviated new drug application (ANDA) for Nelarabine Injection.

Alembic Pharma gets US FDA nod for cancer treatment drug Nelarabine

CSB Bank Ltd, Alembic Pharmaceuticals Ltd, Wonderla Holidays Ltd and Indo Count Industries Ltd are among the other losers in the BSE’s ‘A’ group today, 30 July 2024.

Varun Beverages Ltd leads losers in ‘A’ group

Alembic Pharma’s Panelav unit successfully completes USFDA inspection

Alembic Pharmaceuticals jumped 7.65% to Rs 1,168.75 after the drug maker received final approval from US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA), Fluphenazine Hydrochloride tablets.

Alembic Pharma hits record high on USFDA nod for anti psychotic drug

The Indian market closed lower on Monday as traders preferred to remain on the sidelines in the run up to Budget 2024. The S&P BSE Sensex fell over 100 points while Nifty50 closed above 24,500 levels. Market Roundup

Technical Breakout Stocks: Alembic Pharma, Dr Lal PathLabs and Zydus Wellness hit 52-week highs; what should traders do? - Market Roundup

Nifty and Sensex hit all-time highs, but panic Friday erased gains; Just Dial, Alembic, Hatsun Agro outperform benchmarks.

Just Dial, Alembic Pharmaceuticals and Hatsun Agro Product: Three stocks that outperformed in the week ended July 19

The drug major on Friday announced that it has received a tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Selexipag for injection, 1,800 mcg/vial.

Alembic Pharma gets tentative USFDA nod for Selexipag injection

Buzzing Stocks Today, Stocks that will see action today: July 15, 2024 - Tata Steel, Signature Global, Sunteck Realty, Macrotech Developers, IREDA, RVNL, PTC Industries, Apollo Micro Systems, Tata Power, Apollo Micro, Piramal Pharma, Alembic Pharma, Lupin,EMS, Shantai Industries

Stocks that will see action today: 15 July 2024

Alembic Pharmaceuticals Ltd has obtained final approval from the US FDA for its generic Bromfenac ophthalmic solution, used to treat postoperative inflammation and pain after cataract surgery. The approved product is equivalent to Prolensa Ophthalmic Solution, with an estimated market size of USD 168 million.

Alembic Pharma gets USFDA nod for generic Bromfenac ophthalmic solution

Seedha Sauda Stock Picks: Vijaya Diagnostic & Alembic Pharma में निवेश का यही मौका? | Business News

Seedha Sauda की Picks में से जानें Experts ने इन 2 Stocks पर क्यों दांव लगाने की सलाह ही है, जानें किस Target और Stop Loss के साथ यहां आगे बढ़ा जा सकता है

#vijayadiagnostic #alembicpharma  #stockstobuy #cnbcawaaz #businessnews #stockmarket #sharemarket #AajKaTajaKhabar #cnbcawaaz #marketnews #latestbusinessnews 
n18oc_business

Business News | CNBC Awaaz brings to you latest business news, live share market updates, stock market updates, top business news in india, stock market updates, ipo latest updates, news updates on banking and financials, realty sector and it sector. Watch business news live, business news and share market live updates on CNBC Awaaz. Stay tune to get all the news of pre-opening trades, opening trades, and top calls in pehla sauda. Know what market veterans have to say on the current market trends in big market voices. Watch final trade market strategy, btst stbt calls, intraday strategy and brokerage house calls, quarterly results expectations in kamai ka adda with anuj singhal and virendra kumar. Also stay tune to watch share market tomorrow strategy in kal ka bazaar. Watch CNBC Awaaz and get the best investment ideas.  

CNBC Awaaz is one of India’s top business channels and a leader in business news and information for the last ten years. Our channel aims to educate, inform and inspire consumers to go beyond limitations, with practical tips on personal finance, investing, technology, consumer goods and capital markets. Policymakers and business owners alike have grown to trust CNBC Awaaz as the most reliable source with its eye on India’s business climate. Our programming gives consumers a platform to make decisions with confidence. 

Subscribe to the CNBC Awaaz YouTube channel here: https://tinyurl.com/y5rsvesk

Follow CNBC Awaaz on Twitter: https://twitter.com/CNBC_Awaaz
Like us on our CNBC Awaaz Facebook page: https://www.facebook.com/cnbcawaaz
Website: https://hindi.cnbctv18.com/

Seedha Sauda Stock Picks: Vijaya Diagnostic & Alembic Pharma में निवेश का यही मौका? | Business News

Hasn't fared well - amongst the low performers

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Alembic Pharmaceuticals Limited is a pharmaceutical company engaged in developing formulations and active pharmaceutical ingredients (API).